CM
NXTM

Castleark Management’s NxStage Medical Inc. NXTM Stock Holding History

Castleark Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-403,440
Closed -$8.84M – 435
2015
Q4 		$8.84M Buy
+403,440
New +$7.52M 0.27% 96
2015
Q2 		– Sell
-575,491
Closed -$9.96M – 406
2015
Q1 		$9.96M Buy
575,491
+11,800
+2% +$208K 0.24% 132
2014
Q4 		$10.1M Buy
+563,691
New +$9.08M 0.26% 114
2014
Q3 		– Sell
-325,950
Closed -$4.68M – 357
2014
Q2 		$4.68M Buy
+325,950
New +$4.26M 0.13% 165
2013
Q4 		– Sell
-518,036
Closed -$6.8M – 418
2013
Q3 		$6.8M Buy
518,036
+217,886
+73% +$2.86M 0.19% 139
2013
Q2 		$4.29M Buy
+300,150
New +$3.77M 0.14% 109

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Castleark Management's NXTM Position: Q1 2016 in Review

Castleark Management sold out of NxStage Medical Inc. (NXTM) in Q1 2016, closing a stake of 403,440 shares — an estimated $8.84M sold.

Castleark Management first reported a position in NXTM in Q2 2013 and held it in 6 quarters. The position peaked at $10.1M in Q4 2014. 140 funds tracked by Wall St. Rank hold NXTM as of Q1 2016.

  • Castleark Management reported no remaining NxStage Medical Inc. position as of Q1 2016 after selling out during the quarter.
  • Castleark Management sold 403,440 NxStage Medical Inc. shares in Q1 2016, an estimated $8.84M.
  • Castleark Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 6 quarters.
  • Castleark Management's NxStage Medical Inc. position peaked at $10.1M in Q4 2014.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2016.

Based on Castleark Management's 13F filing for Q1 2016, filed 17 May 2016.